Emergent BioSolutions (EBS) Share-based Compensation Growth (1y) (2011 - 2026)
Emergent BioSolutions (EBS) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.47% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 47.06% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 8.79% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 281.05% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 92.83% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 5.49% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 61.54% |
| 10 | Emergent BioSolutions | 389.77 Mn | 228.27 Mn | 84.10 Mn | 280.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 280.00% |
| Dec 31, 2025 | -109.71% |
| Sep 30, 2025 | -37.84% |
| Jun 30, 2025 | 1.82% |
| Mar 31, 2025 | -91.53% |
| Dec 31, 2024 | -50.24% |
| Sep 30, 2024 | 70.87% |
| Jun 30, 2024 | -57.69% |
| Mar 31, 2024 | 180.95% |
| Dec 31, 2023 | 463.16% |
| Sep 30, 2023 | 23.03% |
| Jun 30, 2023 | -24.42% |
| Mar 31, 2023 | -58.00% |
| Dec 31, 2022 | 69.19% |
| Sep 30, 2022 | -185.49% |
| Jun 30, 2022 | 2,050.00% |
| Mar 31, 2022 | -59.02% |
| Dec 31, 2021 | -147.44% |
| Sep 30, 2021 | 206.04% |
| Jun 30, 2021 | -96.85% |